Utility of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies: a viewpoint from the FDA

被引：0
|
作者：
Penzenstadler, Justin [1 ]
Earp, Justin C. [2 ]
Heickman, Lauren K. Wood K. [1 ]
Pluchino, Kristen [1 ]
机构：
[1] US FDA, Ctr Drug Evaluat & Res, Div Diabet & Lipid Disorders Obesity, Silver Spring, MD 20740 USA
[2] US FDA, Ctr Drug Evaluat & Res, Div Pharmacometr, Silver Spring, MD USA
来源：
DIABETOLOGIA | 2023年 / 66卷 / 03期
关键词：
D O I：
10.1007/s00125-022-05853-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：603 / 604
页数：2
相关论文
共 50 条
  • [41] Relevance of Circulating microRNA, and their Association with Islet Cell Autoantibodies in Type 1 Diabetes Pathogenesis
    Santos, Aritania S.
    Santos-Bezerra, Daniele Pereira
    Ferreira, Ludmila Rodrigues Pinto
    Bando, Silvia Y.
    Alves, Lais Isidoro
    Cunha-Neto, Edecio
    da Silva, Maria Elizabeth Rossi
    ARCHIVES OF MEDICAL RESEARCH, 2025, 56 (02)
  • [42] Pathogenic Action of GAD65 Autoantibodies on Islet Function in Type 1 Diabetes
    Kamat, Varun
    Hampe, Christiane S.
    Sweet, Ian
    DIABETES, 2024, 73
  • [43] Detection and evaluation of islet autoantibodies related to type 1 diabetes by chemiluminescence and western blotting
    Huanhuan, K.
    Xiaosong, Q.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 974 - 975
  • [44] Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis
    Jonsdottir, Berglind
    Larsson, Christer
    Carlsson, Annelie
    Forsander, Gun
    Ivarsson, Sten Anders
    Lernmark, Ake
    Ludvigsson, Johnny
    Marcus, Claude
    Samuelsson, Ulf
    Ortqvist, Eva
    Larsson, Helena Elding
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (04): : 1277 - 1285
  • [45] Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
    Kenney Ng
    Vibha Anand
    Harry Stavropoulos
    Riitta Veijola
    Jorma Toppari
    Marlena Maziarz
    Markus Lundgren
    Kathy Waugh
    Brigitte I. Frohnert
    Frank Martin
    Olivia Lou
    William Hagopian
    Peter Achenbach
    Diabetologia, 2023, 66 : 93 - 104
  • [46] Islet autoantibodies in type-1 or type-2 diabetes in four US racial groups
    Marker, JD
    Chopra, M
    Ten, S
    Su, K
    Zeidler, A
    Raskin, P
    Rappaport, R
    Schatz, D
    Vargas, A
    Malone, J
    Bode, B
    Krischer, J
    MacLaren, NK
    DIABETES, 2001, 50 : A262 - A262
  • [47] Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
    Ng, Kenney
    Anand, Vibha
    Stavropoulos, Harry
    Veijola, Riitta
    Toppari, Jorma
    Maziarz, Marlena
    Lundgren, Markus
    Waugh, Kathy
    Frohnert, Brigitte, I
    Martin, Frank
    Lou, Olivia
    Hagopian, William
    Achenbach, Peter
    DIABETOLOGIA, 2023, 66 (01) : 93 - 104
  • [48] Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes
    Matsumoto, Shinichi
    Abalovich, Adrian
    Wechsler, Carlos
    Wynyard, Shaun
    Elliott, Robert B.
    EBIOMEDICINE, 2016, 12 : 255 - 262
  • [49] Islet transplantation as treatment of type 1 diabetes: from experimental beginnings to clinical application
    Federlin, KF
    Jahr, H
    Bretzel, RG
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 : S373 - S383
  • [50] Slowly progressing type 1 diabetes: Persistence of islet cell autoantibodies is related to glibenclamide treatment
    Cabrera-Rode, E
    Perich, P
    Diaz-Horta, O
    Tiberti, C
    Molina, G
    Arranz, C
    Martin, JM
    Licea, M
    De Leiva, A
    Puig-Domingo, M
    Dimario, U
    AUTOIMMUNITY, 2002, 35 (07) : 469 - 474
12345